Industrial Change and Regional Development: The Case of the US Biotechnology and Pharmaceutical Industries

M Gray and E Parker
Additional contact information
M Gray: Department of Geography, University of Cambridge, Cambridge CB2 3EN, England
E Parker: Project on Regional and Industrial Economics, Rutgers University, New Brunswick, NJ 08903, USA

Environment and Planning A, 1998, vol. 30, issue 10, 1757-1774

Abstract: We examine the arguments surrounding the location and organization of innovative firms and examine the prospects for industry renewal and regional rejuvenation. We examine the effect of technological breakthroughs in the biotechnology industry on the organization and location of production with respect to mature and emergent regions. We find that, despite losing much of their preeminence in research and development, traditional firms in mature regions have managed to ‘capture’ a substantial amount of manufacturing and marketing. The drug-development experience, manufacturing capabilities, and marketing channels of more established companies in mature regions are turning out to be major sources of competitive advantage.

Date: 1998
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (9)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1068/a301757 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:envira:v:30:y:1998:i:10:p:1757-1774

DOI: 10.1068/a301757

Access Statistics for this article

More articles in Environment and Planning A
Bibliographic data for series maintained by SAGE Publications ().